Online Only Articles

Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients

Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Transfusion Medicine and Cell Processing, Tokyo Women’s Medical University, Tokyo, Japan
Department of Transfusion Medicine and Cell Processing, Tokyo Women’s Medical University, Tokyo, Japan
Department of Transfusion Medicine and Cell Processing, Tokyo Women’s Medical University, Tokyo, Japan
Department of Hematology
Vol. 105 No. 4 (2020): April, 2020 https://doi.org/10.3324/haematol.2019.226696